Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Age-Related Measurements of the Myelin Water Fraction derived from 3D multi-echo GRASE reflect Myelin Content of the Cerebral White Matter.

Faizy TD, Kumar D, Broocks G, Thaler C, Flottmann F, Leischner H, Kutzner D, Hewera S, Dotzauer D, Stellmann JP, Reddy R, Fiehler J, Sedlacik J, Gellißen S.

Sci Rep. 2018 Oct 9;8(1):14991. doi: 10.1038/s41598-018-33112-8.

2.

Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.

Rahn AC, Köpke S, Stellmann JP, Schiffmann I, Lukas C, Chard D, Heesen C.

Acta Neurol Scand. 2018 Aug 8. doi: 10.1111/ane.13010. [Epub ahead of print] Review.

PMID:
30091223
3.

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.

Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O.

Front Hum Neurosci. 2018 Jun 4;12:226. doi: 10.3389/fnhum.2018.00226. eCollection 2018.

4.

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6.

5.

Distribution of brain sodium long and short relaxation times and concentrations: a multi-echo ultra-high field 23Na MRI study.

Ridley B, Nagel AM, Bydder M, Maarouf A, Stellmann JP, Gherib S, Verneuil J, Viout P, Guye M, Ranjeva JP, Zaaraoui W.

Sci Rep. 2018 Mar 12;8(1):4357. doi: 10.1038/s41598-018-22711-0.

6.

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).

Stürner KH, Stellmann JP, Dörr J, Paul F, Friede T, Schammler S, Reinhardt S, Gellissen S, Weissflog G, Faizy TD, Werz O, Fleischer S, Vaas LAI, Herrmann F, Pless O, Martin R, Heesen C.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):330-338. doi: 10.1136/jnnp-2017-317101. Epub 2017 Dec 16.

PMID:
29248894
7.

Perceptions on the value of bodily functions in multiple sclerosis.

Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Paul F, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann JP.

Acta Neurol Scand. 2018 Mar;137(3):356-362. doi: 10.1111/ane.12881. Epub 2017 Dec 3.

PMID:
29205262
8.

The use of multiparametric quantitative magnetic resonance imaging for evaluating visually assigned lesion groups in patients with multiple sclerosis.

Thaler C, Faizy TD, Sedlacik J, Bester M, Stellmann JP, Heesen C, Fiehler J, Siemonsen S.

J Neurol. 2018 Jan;265(1):127-133. doi: 10.1007/s00415-017-8683-9. Epub 2017 Nov 20.

PMID:
29159467
9.

Low clinical conversion rate in clinically isolated syndrome patients - diagnostic benefit of McDonald 2010 criteria?

Rosenkranz SC, Kaulen B, Neuhaus A, Siemonsen S, Köpke S, Daumer M, Stellmann JP, Heesen C.

Eur J Neurol. 2018 Feb;25(2):247-e9. doi: 10.1111/ene.13476. Epub 2017 Dec 2.

PMID:
29024243
10.

Reduced rich-club connectivity is related to disability in primary progressive MS.

Stellmann JP, Hodecker S, Cheng B, Wanke N, Young KL, Hilgetag C, Gerloff C, Heesen C, Thomalla G, Siemonsen S.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 27;4(5):e375. doi: 10.1212/NXI.0000000000000375. eCollection 2017 Sep.

11.

T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.

Thaler C, Schneider T, Sedlacik J, Kutzner D, Stellmann JP, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2017 Aug 10;12(8):e0183099. doi: 10.1371/journal.pone.0183099. eCollection 2017.

12.

Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?

Kjølhede T, Siemonsen S, Wenzel D, Stellmann JP, Ringgaard S, Pedersen BG, Stenager E, Petersen T, Vissing K, Heesen C, Dalgas U.

Mult Scler. 2018 Sep;24(10):1356-1365. doi: 10.1177/1352458517722645. Epub 2017 Jul 28.

PMID:
28752800
13.

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group).

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1.

14.

No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis.

Stellmann JP, Young KL, Vettorazzi E, Pöttgen J, Heesen C.

Eur J Neurol. 2017 Jun;24(6):851-857. doi: 10.1111/ene.13301.

PMID:
28544407
15.

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.

Stellmann JP, Cetin H, Young KL, Hodecker S, Pöttgen J, Bittersohl D, Hassenstein A, Oberwahrenbrock T, Heesen C, Siemonsen S.

Brain Behav. 2016 Dec 20;7(2):e00614. doi: 10.1002/brb3.614. eCollection 2017 Feb.

16.

Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.

Faizy TD, Thaler C, Ceyrowski T, Broocks G, Treffler N, Sedlacik J, Stürner K, Stellmann JP, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2017 Feb 24;12(2):e0172923. doi: 10.1371/journal.pone.0172923. eCollection 2017.

17.

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report.

Hodecker SC, Stellmann JP, Rosenkranz SC, Young K, Holst B, Friese MA, Heesen C.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e328. doi: 10.1212/NXI.0000000000000328. eCollection 2017 Mar. No abstract available.

18.

T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.

Thaler C, Faizy TD, Sedlacik J, Holst B, Stürner K, Heesen C, Stellmann JP, Fiehler J, Siemonsen S.

AJNR Am J Neuroradiol. 2017 Feb;38(2):264-269. doi: 10.3174/ajnr.A5004. Epub 2016 Nov 10.

19.

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group).

Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6.

PMID:
27758954
20.

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting.

von Gumberz J, Mahmoudi M, Young K, Schippling S, Martin R, Heesen C, Siemonsen S, Stellmann JP.

PeerJ. 2016 Sep 20;4:e2442. doi: 10.7717/peerj.2442. eCollection 2016.

21.

Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.

Stellmann JP, Jlussi M, Neuhaus A, Lederer C, Daumer M, Heesen C.

J Neurol Sci. 2016 Sep 15;368:318-25. doi: 10.1016/j.jns.2016.07.051. Epub 2016 Jul 25.

PMID:
27538657
22.

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, Limmroth V, Linker RA, Loleit V, Luessi F, Meuth SG, Mühlau M, Nischwitz S, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Arloth J, Weber P, Radivojkov-Blagojevic M, Scheinhardt MO, Dankowski T, Bettecken T, Lichtner P, Czamara D, Carrillo-Roa T, Binder EB, Berger K, Bertram L, Franke A, Gieger C, Herms S, Homuth G, Ising M, Jöckel KH, Kacprowski T, Kloiber S, Laudes M, Lieb W, Lill CM, Lucae S, Meitinger T, Moebus S, Müller-Nurasyid M, Nöthen MM, Petersmann A, Rawal R, Schminke U, Strauch K, Völzke H, Waldenberger M, Wellmann J, Porcu E, Mulas A, Pitzalis M, Sidore C, Zara I, Cucca F, Zoledziewska M, Ziegler A, Hemmer B, Müller-Myhsok B.

Sci Adv. 2016 Jun 17;2(6):e1501678. doi: 10.1126/sciadv.1501678. eCollection 2016 Jun.

23.

Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.

Faizy TD, Thaler C, Kumar D, Sedlacik J, Broocks G, Grosser M, Stellmann JP, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2016 Mar 18;11(3):e0151496. doi: 10.1371/journal.pone.0151496. eCollection 2016.

24.

"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.

Zeidman LA, von Villiez A, Stellmann JP, van den Bussche H.

J Hist Neurosci. 2016 Jul-Sep;25(3):275-98. doi: 10.1080/0964704X.2015.1121696. Epub 2016 Feb 10.

PMID:
26863588
25.

Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.

Galler S, Stellmann JP, Young KL, Kutzner D, Heesen C, Fiehler J, Siemonsen S.

AJNR Am J Neuroradiol. 2016 May;37(5):963-9. doi: 10.3174/ajnr.A4638. Epub 2016 Jan 7.

26.

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.

Thaler C, Faizy T, Sedlacik J, Holst B, Stellmann JP, Young KL, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2015 Dec 11;10(12):e0144693. doi: 10.1371/journal.pone.0144693. eCollection 2015.

27.

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; Neuromyelitis Optica Study Group.

Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26.

PMID:
26537743
28.

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients.

Bester M, Forkert ND, Stellmann JP, Stürner K, Aly L, Drabik A, Young KL, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2015 Nov 4;10(11):e0142464. doi: 10.1371/journal.pone.0142464. eCollection 2015. No abstract available.

29.

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.

Dankowski T, Buck D, Andlauer TF, Antony G, Bayas A, Bechmann L, Berthele A, Bettecken T, Chan A, Franke A, Gold R, Graetz C, Haas J, Hecker M, Herms S, Infante-Duarte C, Jöckel KH, Kieseier BC, Knier B, Knop M, Kümpfel T, Lichtner P, Lieb W, Lill CM, Limmroth V, Linker RA, Loleit V, Meuth SG, Moebus S, Müller-Myhsok B, Nischwitz S, Nöthen MM, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Strauch K, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Waldenberger M, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Hemmer B, Ziegler A; German Competence Network for Multiple Sclerosis (KKNMS).

Genet Epidemiol. 2015 Dec;39(8):601-8. doi: 10.1002/gepi.21933. Epub 2015 Oct 26.

PMID:
26497834
30.

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients.

Stellmann JP, Young KL, Pöttgen J, Dorr M, Heesen C.

Mult Scler J Exp Transl Clin. 2015 Jul 21;1:2055217315596184. doi: 10.1177/2055217315596184. eCollection 2015 Jan-Dec.

31.

[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research].

Stellmann JP, Stürner KH, Ufer F, Havemeister S, Pöttgen J, Ayuk Ayuketang F, Kröger N, Friese MA, Heesen C.

Nervenarzt. 2015 Aug;86(8):989-96. doi: 10.1007/s00115-015-4305-x. German.

PMID:
25956824
32.

Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging.

Siemonsen S, Young KL, Bester M, Sedlacik J, Heesen C, Fiehler J, Stellmann JP.

Clin Neuroradiol. 2016 Dec;26(4):457-464. Epub 2015 Apr 18.

PMID:
25895017
33.

Ecological validity of walking capacity tests in multiple sclerosis.

Stellmann JP, Neuhaus A, Götze N, Briken S, Lederer C, Schimpl M, Heesen C, Daumer M.

PLoS One. 2015 Apr 16;10(4):e0123822. doi: 10.1371/journal.pone.0123822. eCollection 2015.

34.

Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.

Bester M, Forkert ND, Stellmann JP, Stürner K, Aly L, Drabik A, Young KL, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2015 Mar 16;10(3):e0119356. doi: 10.1371/journal.pone.0119356. eCollection 2015. Erratum in: PLoS One. 2015;10(11):e0142464. Stürner, Klarissa [added].

35.

Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?

Stellmann JP, Stürner KH, Young KL, Siemonsen S, Friede T, Heesen C.

PLoS One. 2015 Feb 6;10(2):e0116559. doi: 10.1371/journal.pone.0116559. eCollection 2015. Review.

36.

Magnetic resonance imaging in multiple sclerosis--patients' experiences, information interests and responses to an education programme.

Brand J, Köpke S, Kasper J, Rahn A, Backhus I, Poettgen J, Stellmann JP, Siemonsen S, Heesen C.

PLoS One. 2014 Nov 21;9(11):e113252. doi: 10.1371/journal.pone.0113252. eCollection 2014.

37.

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.

Sospedra M, Schippling S, Yousef S, Jelcic I, Bofill-Mas S, Planas R, Stellmann JP, Demina V, Cinque P, Garcea R, Croughs T, Girones R, Martin R.

Clin Infect Dis. 2014 Dec 1;59(11):1588-92. doi: 10.1093/cid/ciu682. Epub 2014 Sep 11.

38.

A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.

Stellmann JP, Vettorazzi E, Poettgen J, Heesen C.

J Neurol Sci. 2014 Nov 15;346(1-2):99-106. doi: 10.1016/j.jns.2014.08.001. Epub 2014 Aug 10.

PMID:
25156343
39.

Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.

Stellmann JP, Neuhaus A, Lederer C, Daumer M, Heesen C.

PLoS One. 2014 Mar 20;9(3):e92761. doi: 10.1371/journal.pone.0092761. eCollection 2014. Review.

40.

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.

Lutterotti A, Yousef S, Sputtek A, Stürner KH, Stellmann JP, Breiden P, Reinhardt S, Schulze C, Bester M, Heesen C, Schippling S, Miller SD, Sospedra M, Martin R.

Sci Transl Med. 2013 Jun 5;5(188):188ra75. doi: 10.1126/scitranslmed.3006168.

41.

Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.

Heesen C, Gaissmaier W, Nguyen F, Stellmann JP, Kasper J, Köpke S, Lederer C, Neuhaus A, Daumer M.

PLoS One. 2013 May 17;8(5):e59042. doi: 10.1371/journal.pone.0059042. Print 2013.

42.

Comparison of patient-reported outcome measures in multiple sclerosis.

Schäffler N, Schönberg P, Stephan J, Stellmann JP, Gold SM, Heesen C.

Acta Neurol Scand. 2013 Aug;128(2):114-21. doi: 10.1111/ane.12083. Epub 2013 Feb 7.

PMID:
23398571
43.

Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.

Stellmann JP, Neuhaus A, Herich L, Schippling S, Roeckel M, Daumer M, Martin R, Heesen C.

PLoS One. 2012;7(11):e50347. doi: 10.1371/journal.pone.0050347. Epub 2012 Nov 29.

44.

Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.

Hofmann A, Stellmann JP, Kasper J, Ufer F, Elias WG, Pauly I, Repenthin J, Rosenkranz T, Weber T, Köpke S, Heesen C; MS Network Hamburg.

Mult Scler. 2013 Jun;19(7):920-5. doi: 10.1177/1352458512461967. Epub 2012 Oct 4.

PMID:
23037548
45.

[Chronic facial pain due to a brainstem cavernoma].

Stellmann JP, Kuhn M, Töpper R.

Fortschr Neurol Psychiatr. 2007 Sep;75(9):552-4. Epub 2007 Jul 24. German.

PMID:
17647150

Supplemental Content

Loading ...
Support Center